Wellness & Lifestyle

Tilda Research deploys AI Teammates designed to perform the operational work of clinical trials with unprecedented precision and speed. These AI teammates integrate seamlessly with existing tools and processes for sponsors, CROs, and sites, simplifying trial management and potentially reducing study timelines by up to 70%. The platform focuses on achieving better data quality, faster timelines, real-time centralized monitoring, and seamless regulatory compliance. For sites, Tilda Research offers automated workflows to reduce burden, increase financial performance by boosting collection rates and reducing revenue leakage, and helps them participate in more studies. The system is built to be an intelligent, automated, and integrated workflow AI platform for clinical trials.

Biorce offers Aika, an AI-native platform designed to accelerate clinical trials. Aika unifies solutions for protocol design, feasibility, and regulatory planning into one intuitive workspace, helping clinical teams reduce trial setup time, mitigate risks, and bring treatments to patients faster. The platform provides AI-accelerated protocol creation, aids in amendment prevention, and offers 100% explainable decisions based on approximately one million real trials. Biorce aims to address the challenge of explainability in AI for clinical trials, providing a transparency report for Aika. It is built by former CRO, clinicians, regulatory, and AI leaders, and is used across US, EU, and APAC by global clinical trial teams.

Clairity, Inc. offers Clairity Breast, the first FDA-authorized AI platform designed to predict a woman’s five-year future risk of developing breast cancer. This innovative tool analyzes existing screening mammograms to uncover hidden clues, invisible to the human eye, that help predict future risk. By delivering validated and equitable risk assessments, Clairity aims to expand access to life-saving early detection and prevention for women. The platform supports new NCCN Guidelines that call for AI-based mammogram risk assessment starting at age 35, representing a major paradigm shift in breast cancer screening.

Artha's SeeHaptic is a groundbreaking haptic technology designed to significantly improve the perception of the environment and mobility for people with visual impairments and blindness. This innovative solution translates visual information into tactile sensations, providing an intuitive, immediate, and accessible way to understand surroundings. The core of SeeHaptic lies in its ability to allow users to "see" with their brain through their skin, enabling them to navigate spaces more freely and confidently. It's presented as a simple, accessible, and instinctive device, allowing for natural use from the outset. The technology aims to offer a new sense of freedom by transforming how individuals interact with their environment.

EarlyDiagnostics (EarlyDx) is dedicated to advancing cancer detection and precision medicine through its innovative liquid biopsy tests. The company has developed CancerRadar, a highly accurate and sensitive blood test for detecting and locating cancer. Additionally, EarlyDx offers EarlyDx-Cloud, a comprehensive bioinformatics solution designed to assist diagnostic companies in offering liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring. Their core technologies include cfMethyl-seq for profiling cfDNA methylome, cfSNV for accurately calling mutations from blood, and cfTrack for non-invasive monitoring of cancer MRD, recurrence, and evolution. EarlyDx aims to provide accessible and reliable tools for early disease diagnostics.

Forta Health offers accessible Applied Behavior Analysis (ABA) therapy for children with autism, available virtually across 43 states and in-home in select cities. The platform connects families with board-certified BCBAs and RBTs to deliver personalized, evidence-based care. Forta emphasizes active parent involvement in every session, teaching strategies for lifelong support. A key differentiator is the elimination of waitlists, allowing families to start professional therapy within 90 days. Forta accepts over 300 insurance plans, including Medicaid, and provides a streamlined intake process to quickly match children with the right service. The therapy focuses on improving behavior, developing social skills, building communication abilities, and increasing independence within the child's natural environment.

Ema is a leading AI platform specifically designed for women's health and wellness. It functions as an emotionally intelligent care platform, leveraging a vast dataset of over 10 million real health conversations to provide personalized support. The platform is built with a focus on women's health but is perfected for everyone, indicating a broad applicability while maintaining its core specialization. Ema has been clinically validated by more than 50 advisors, underscoring its reliability and scientific backing. It aims to offer comprehensive AI-driven health and wellness solutions, making it a valuable tool for individuals seeking intelligent and empathetic health guidance.

SereniMind is a leading mental health platform based in Nigeria, providing accessible online counseling services across Africa. The platform connects users with expert counselors who offer personalized support to address various mental health challenges, including depression, anxiety, and stress. SereniMind aims to make mental well-being support readily available, helping individuals navigate their mental health journey from the comfort of their homes. It focuses on delivering professional and tailored services to promote better mental health outcomes for its users.

RejuveAI is a decentralized platform empowering longevity research and personalized insights through cutting-edge AI innovations. It aims to democratize longevity globally by allowing users to take control of their health data and harness its earning potential. The Rejuve Longevity App enables users to monitor essential health metrics, enhance their lifespan, and accumulate RJV tokens. These tokens unlock exclusive discounts on travel, supplements, medical tests, and longevity therapies. Rejuve unites researchers, clinics, and data enthusiasts in a decentralized collaboration to combat aging, ensuring innovative outcomes are affordable and accessible. Its technology uses revolutionary AI for human body analysis, crafting intricate, dynamic models of bodily functions, enriched with data from participants and various biological and medical databases. The platform also supports decentralized N-of-1 trials to generate personalized evidence on longevity optimization strategies.

Hale is a HIPAA-compliant health intelligence platform designed for individuals managing chronic conditions such as Multiple Sclerosis, Heart Disease, Diabetes, Fibromyalgia, and Autism. It centralizes medications, lab results, and appointments, providing personalized guidance based on the user's specific medical history. Built by a heart attack survivor, Hale aims to offer clear health insights and support confident decision-making. Key features include medication tracking, medical report interpretation, and personalized answers to health questions, all while ensuring data privacy with HIPAA compliance, encryption, and zero AI data retention. Hale also offers a Family Plan for caregivers to manage the health of loved ones.

Yidu Tech Inc. offers comprehensive AI-driven healthcare solutions, leveraging its proprietary YiduCore medical intelligence infrastructure. This platform provides data analysis and evidence-based decision-making capabilities to various healthcare industry participants. The company assists hospitals in building big data analysis platforms for research, clinical, and management scenarios, and helps regional governments enhance public health safety and resource efficiency. For life science companies, Yidu Tech offers end-to-end solutions covering drug development, clinical operations, and post-market research. Additionally, it provides AI-driven chronic disease management for patients and insurance technology services to insurance companies, aiming to improve efficiency and product value across the healthcare ecosystem.

Carta Healthcare offers an AI platform designed for hospitals and health systems to manage enterprise clinical data efficiently. Utilizing a unique 'Hybrid Intelligence' approach, which combines AI with expert human abstractors, the platform aims to drastically reduce costs, supercharge efficiency, save time, and enhance data quality. Key components include Voyager, an AI data platform; Lighthouse, an AI-assisted abstraction tool; and Navigator, for clinical data intelligence. It also provides expert abstraction services for flexible outsourcing or staff augmentation, helping organizations improve IRR scores and accelerate research through rapid data analysis and cohort selection for clinical trials.

Cephalgo pioneers speech-based analysis for mental health assessment, offering objective and remote measurement of symptoms through voice analysis. The platform provides research-validated voice technology with built-in regulatory compliance for digital health and clinical assessment platforms. Key offerings include peer-reviewed algorithms for assessment, an API-ready platform for seamless integration into digital health ecosystems and clinical trials, and compliance with GDPR, HIPAA, and EU AI Act readiness. Cephalgo focuses on real-world validation, with studies across diverse populations, and has projects like ADAPTE for accessible voice emotion analysis, OPADE for Major Depressive Disorder biosignal signatures, and ReSonate for biosignal-monitored therapeutic protocols for depression.

CompassRx is an AI-enabled service designed to help 340B covered entities maximize growth and navigate constant regulatory changes within the pharmacy industry. Founded by a team of AI and pharmacy experts, the platform offers automated eligibility workflows to ensure compliance and efficiency. It also provides smart pharmacy engagement tools and personalized medication adherence solutions to bolster patient engagement and support care plans. CompassRx aims to reduce the burden on overworked pharmacy teams facing staffing shortages and increasing demands, helping them complete necessary work and avoid leaving revenue on the table. The communication tool also assists in navigating patients to in-house pharmacies, addressing challenges posed by contract pharmacy restrictions.

23Strands is a healthcare platform dedicated to empowering individuals and clinicians through genomics. The tool utilizes whole genome sequencing to analyze an individual's entire DNA, providing comprehensive, personalized health insights. It partners with local and global clinical networks to offer actionable treatment strategies and supports clinical decision-making by integrating genomic, medical, and pharmacological information. 23Strands also offers Fertility23, a specialized service to identify genetic causes of infertility. The platform aims to integrate seamlessly with practice management software and electronic health record systems, giving clinicians a complete view of their patients' genomic health information.

Previu Health is India's first care navigation company, focusing on bridging the gap between diagnosis and completed care, particularly for critical diseases like cancer. The platform offers services for cancer screening, early detection, and treatment, aiming to significantly improve care completion rates compared to national averages. Previu Health partners with labs, communities, and employers across India to provide comprehensive oncology care, including HPV vaccination and chemotherapy. The company emphasizes affordable cancer screening and treatment, with a strong presence in Bangalore.

Remmie Health provides FDA-registered smart digital otoscopes designed for convenient at-home ear, nose, and throat examinations. The devices, such as Remmie 3 and Remmie 4, integrate with the Remmie App and Remmie.ai to capture and stream high-quality visuals, facilitating fast telehealth consultations and pre-visit assessments. Users can identify symptoms, share images or live video with physicians, and receive remote diagnoses, potentially avoiding unnecessary in-person doctor visits. The system is AI-guided for easier image capture and supports real-time video streaming, image/video recording, and monitoring for various conditions like ear infections, pink eye, and strep throat. It aims to reduce costs and save time by enabling remote care.

Zealth AI specializes in healthcare AI strategy and product leadership, collaborating with a diverse range of clients including hospitals, pharmaceutical companies, insurers, and healthtech organizations. The platform's core mission is to translate AI innovation into tangible healthcare outcomes, providing expertise in strategic planning, venture building, and product development within the AI healthcare sector. It aims to guide organizations through the complexities of integrating AI, ensuring that technological advancements lead to improved patient care, operational efficiency, and new market opportunities. Zealth AI's approach emphasizes practical application and leadership to drive meaningful change in the healthcare industry.

Naatscorp Private Limited, established in 2022 and recognized by DPIIT, is a pioneering venture dedicated to crafting assistive technology solutions. Their vision is to create a future where technology acts as a catalyst for self-reliance, empowering individuals to navigate life with confidence and autonomy. Naatscorp's commitment to research and development drives advancements that redefine possibilities, ensuring every step towards independence is a stride towards a life lived with dignity. They offer three distinct business verticals: Research & Development, Contract Manufacturing, and Product Manufacturing, all united in fostering an ecosystem of innovation and expertise. The company is ISO 13485 QMS certified for AI-enabled Fully Automated Robotic Nursing Assistance devices and ISO 9001 certified for manufacturing processes, emphasizing their dedication to quality and excellence.

Arctop is a state-of-the-art software infrastructure and API platform designed for Human-AI Interfacing, bridging the gap between human biology and technology. It decodes brain activity to provide objective measures of cognition, offering unprecedented insights into human mental states. The platform enables new forms of communication and interaction by relating brain activity to specific intentions. Arctop also features Brain ID, a continuous biometric authentication system that identifies unique brain signatures for convenient security without traditional usernames or passwords. The technology processes brain signals to track focus, enjoyment, visual attention, cognitive workload, and auditory attention, making it a trusted partner for B2B and B2G customers since 2016.

Red Sky Health offers an AI-driven platform, Daniel, designed to automate the identification, correction, and resubmission of health insurance claim denials at scale. The platform provides real-time KPIs, metrics, and insights through a comprehensive dashboard, tracking denial charges, counts, and remitted amounts across all payers. Daniel AI performs advanced analysis of each denial, considering complete claim context including coverage validity and authorization requirements, and surfaces critical information like ICD-10 codes and payer-specific limitations. It also features centralized state assignment and workflow management for denials, along with automated remediation and resubmission workflows. This solution aims to reduce denial rates by 20-40%, shorten AR cycles, and improve cash flow for healthcare providers.

HealMed Solutions, Inc. offers an AI-driven platform designed to address the severe shortages of mental health providers and increasing caseloads. The system automates patient mental health assessments, stratifies responses, and provides an AI-based Clinical Decision Support System (CDSS) to improve patient outcomes. It empowers healthcare providers to manage high patient volumes, streamline billing, and maximize revenue potential, while significantly reducing workloads by up to 75-80%. HealMed also integrates with Behavioral Health Integration (BHI) and Coordinated Care Management (CoCM) workflows, ensuring efficient coordination. Patients benefit from reduced wait times, privacy, accuracy due to AI, and the option for teleconsultations, all within a secure, HIPAA-compliant platform.

FiveBrane is a powerful data science platform specifically designed for medical imaging AI teams. It integrates the collaborative features of a version control system with compliance-aware workflows, smart data infrastructure, and clinical expertise. The platform empowers Med-Tech AI teams to develop reliable, robust, compliant, and cost-effective AI solutions. Key benefits include shortening time to market by accelerating and de-risking the development process, providing smart data access, bias detection, and debugging tools built with regulatory compliance in mind. FiveBrane also facilitates seamless collaboration with medical professionals and helps unlock siloed data, ultimately leading to more robust AI models that perform effectively in real-world scenarios.

Lightbeam Health Solutions provides a comprehensive suite of AI-enabled solutions and services designed for value-based care enablement. Their platform features an AI-Ready Data Orchestration Platform and an AI-Driven Risk Stratification Engine, allowing healthcare organizations to predict and stratify high-risk and rising-risk patients. Key offerings include Risk Adjustment Optimization, Quality Measure Optimization, Automated Patient Engagement, Remote Patient Monitoring, and Referral Management. The solutions deliver actionable insights directly into EHR workflows, helping to close care gaps, reduce avoidable utilization, and improve patient outcomes. Lightbeam also offers Clinical & Financial Advisory Services and boasts significant achievements in cost savings and patient impact.